Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania
Status:
Completed
Trial end date:
2021-01-06
Target enrollment:
Participant gender:
Summary
This is a phase II, randomized study of 120 adults age 18 or above who will prescribed 20mg
daily Fluoxetine for 90 days following acute, ischemic stroke.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Muhimbili University of Health and Allied Sciences